Genus plc (LON:GNS – Get Free Report) insider Celia Baxter purchased 2,336 shares of the company’s stock in a transaction dated Friday, June 26th. The shares were acquired at an average cost of GBX 2,140 per share, with a total value of £49,990.40.
Genus Stock Performance
Shares of Genus stock opened at GBX 2,138.24 on Monday. The stock has a market cap of £1.42 billion, a price-to-earnings ratio of 30.12, a P/E/G ratio of 2.87 and a beta of 0.90. Genus plc has a twelve month low of GBX 1,972 and a twelve month high of GBX 3,220. The company’s fifty day moving average is GBX 2,324.17 and its 200 day moving average is GBX 2,587.02. The company has a quick ratio of 1.08, a current ratio of 2.25 and a debt-to-equity ratio of 51.73.
Analyst Ratings Changes
Separately, Berenberg Bank reaffirmed a “buy” rating and issued a GBX 3,350 price objective on shares of Genus in a research note on Monday, May 11th. Three investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company currently has an average rating of “Buy” and an average target price of GBX 3,216.67.
About Genus
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.
Featured Stories
- Five stocks we like better than Genus
- Winnebago Misses Estimates, But Surges 14% After Earnings
- As Stablecoins Keep Growing, These 2 Stocks Benefit
- Apple Just Handed These 4 Memory Stocks Their Best News of the Year
- Costco’s Secret Growth Engine May Be Running Out of Gas
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.
